ICW Investment Advisors LLC Grows Position in Mettler-Toledo International Inc. (NYSE:MTD)

ICW Investment Advisors LLC raised its position in Mettler-Toledo International Inc. (NYSE:MTDFree Report) by 28.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 224 shares of the medical instruments supplier’s stock after purchasing an additional 50 shares during the period. ICW Investment Advisors LLC’s holdings in Mettler-Toledo International were worth $274,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. State Street Corp grew its holdings in Mettler-Toledo International by 1.0% in the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after purchasing an additional 9,009 shares during the last quarter. Geode Capital Management LLC grew its holdings in Mettler-Toledo International by 0.8% in the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after purchasing an additional 4,166 shares during the last quarter. Principal Financial Group Inc. grew its holdings in Mettler-Toledo International by 13.9% in the fourth quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after purchasing an additional 33,456 shares during the last quarter. Barclays PLC grew its holdings in Mettler-Toledo International by 8.3% in the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after purchasing an additional 19,609 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after purchasing an additional 28,478 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Citigroup lowered their target price on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating on the stock in a report on Tuesday, March 4th. Wolfe Research started coverage on Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating on the stock. Robert W. Baird increased their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Wells Fargo & Company increased their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, February 10th. Finally, Evercore ISI increased their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $1,380.50.

Read Our Latest Stock Analysis on Mettler-Toledo International

Mettler-Toledo International Trading Down 0.2 %

Shares of NYSE:MTD opened at $1,198.09 on Monday. The stock’s 50-day moving average price is $1,292.72 and its two-hundred day moving average price is $1,309.68. Mettler-Toledo International Inc. has a 12-month low of $1,142.91 and a 12-month high of $1,546.93. The firm has a market cap of $24.97 billion, a price-to-earnings ratio of 29.56, a PEG ratio of 3.30 and a beta of 1.15.

Mettler-Toledo International (NYSE:MTDGet Free Report) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, research analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other news, insider Christian Magloth sold 790 shares of the firm’s stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the transaction, the insider now directly owns 734 shares in the company, valued at $964,248.46. This trade represents a 51.84 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now owns 6 shares in the company, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

About Mettler-Toledo International

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Featured Stories

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.